This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Duke University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations in Cardiac Treatment by Cathleen S Colon-Emeric
Introduction
Cathleen S Colon-Emeric is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of cardiac health through her innovative research and patented inventions. With a total of 2 patents, her work focuses on improving treatments for cardiac dysfunction.
Latest Patents
Colon-Emeric's latest patents include groundbreaking methods and compositions for treating cardiac dysfunction. One of her notable inventions is titled "Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction." This invention provides methods for administering a therapeutically effective amount of a bisphosphonate to increase the activity of at least one kinase in heart tissue. Another significant patent is "Methods for treating heart failure using bisphosphonate compositions," which outlines methods for treating and reducing cardiac dysfunction through similar therapeutic approaches.
Career Highlights
Colon-Emeric is affiliated with Duke University, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to significantly impact the management of heart failure and related conditions.
Collaborations
Some of her notable coworkers include Kenneth W Lyles and Christopher M O'Connor, who contribute to her research efforts and advancements in cardiac treatment.
Conclusion
Cathleen S Colon-Emeric's contributions to cardiac health through her patents and research at Duke University highlight her role as an influential inventor in the medical field. Her innovative approaches to treating cardiac dysfunction have the potential to improve patient outcomes significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
